Open AccessRosiglitazone alleviates lipopolysaccharide‑induced inflammation in RAW264.7 cells via inhibition of NF‑κB and in a PPARγ‑dependent manner
Author(s) -
Jingping Zhou,
Xiaoning Yang,
Song Yang,
Fei Zhou,
Jingjing Liu,
Yiqun Hu,
Ligang Chen
Publication year - 2021
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2021.10175
Subject(s) - rosiglitazone , viability assay , inflammation , lipopolysaccharide , peroxisome proliferator activated receptor , chemistry , nf κb , mtt assay , tumor necrosis factor alpha , pharmacology , downregulation and upregulation , proinflammatory cytokine , apoptosis , receptor , endocrinology , medicine , biology , biochemistry , gene